Funding for this research was provided by:
JSPS KAKENHI (26460422, 15K08374, 15604475, 15551829)
Text and Data Mining valid from 2018-05-02
Received: 8 March 2017
Accepted: 19 April 2018
First Online: 2 May 2018
Ethics approval and consent to participate
: The studies of germline and somatic mutations of FLCN and related molecular analyses were approved by the Institutional Review Boards of Yokohama City University (A161100001), and written informed consent for the studies was obtained from the patient. We confirmed that all processes were performed in accordance with the relevant guidelines including the CARE case report guidelines.
: Written informed consent for publication of the patient’s clinical details and/or clinical images was obtained from the patient. A copy of the consent form is available for review by the editor of this journal.
: The authors declare that they have no competing interests.Funding: This work was supported in part by JSPS KAKENHI grant number 26460422 (M.F.) 15 K08374 (Y.N.), 15,604,475 (M.B.), 15,551,829 (M.B.) and Project Mirai Cancer Research Grants (M.F.) in the writing of the manuscript.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.